3 Things To Know As Inversion Rules Muddle Medtronic Deal

New rules unveiled last week to rein in a recent flurry of tax-motivated mergers and acquisitions effectively upend the way deal makers can approach controversial inversion deals, meanwhile leaving one of...

Already a subscriber? Click here to view full article